ClouDr is Listed on the SEHK with Opening Market Share Worth Over HKD 17 Bn

Healthcare Author: Mingxia Ren Jul 07, 2022 11:00 PM (GMT+8)

ClouDr, the largest digital chronic condition management solution provider in China, will continue to bring digital healthcare to every household.


ClouDr (Chinese: 智云健康), the one-stop chronic disease management and smart medical platform in China, is listed on the Stock Exchange of Hong Kong with its opening market share worth over HKD 17 billion on 6 June.

According to its prospectus, the business expansion occupies 60% of its capital, among which the continuous expansion of hospitals and departments is an essential part. Besides, the company will continue to enlarge hospital networks and connect with more industry professionals in the industrial chain. ClouDr will also expand its capacity in digital technology, medical knowledge and product innovation.

Founded in 2014, ClouDr is devoted to building stronger trust between doctors and patients, making the healthcare system more efficient and improving the allocation of medical resources by leveraging internet technologies. The company aspires to lead China’s digital chronic condition management market through its solutions serving all major participants in the healthcare value chain, including hospitals, pharmacies, pharmaceutical companies, patients and doctors.

ClouDr's competitors include Winning Health (Chinese: 卫宁健康), Goodwill (Chinese: 嘉和美康) and B-Soft (Chinese: 创业慧康).